METTL1 tRNA methyltransferase inhibitor therapy(Storm Therapeutics)

N/A

Report date: 2024/02/01 15:54:42
First In Class

Base Information

Drug NameMETTL1 tRNA methyltransferase inhibitor therapy(Storm Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMethyltransferase Like 1 inhibitors
TargetsMethyltransferase Like 1
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStorm Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesStorm Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A